Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

16.1K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

151
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
151

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma cell-free transcriptome profiling in blood plasma from chronic liver disease patients.

Scientific data·2026
Same author

A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells.

JHEP reports : innovation in hepatology·2026
Same author

Assessing nutritional and hydration status in patients with a diabetic foot ulcer: Agreement between hand-to-hand and hand-to-foot bioimpedance methods.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same author

Evolution of muscle mass and strength in patients admitted for a diabetic foot ulcer.

Acta clinica Belgica·2025
Same author

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration.

Clinical epigenetics·2025
Same author

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1.

Journal of Crohn's & colitis·2025

Related Experiment Video

Updated: Jan 4, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.3K

Transcriptional Network Analysis Implicates Altered Hepatic Immune Function in NASH development and resolution.

Joel T Haas1, Luisa Vonghia2,3, Denis A Mogilenko1

  • 1University of Lille, EGID, Inserm, CHU Lille, Institut Pasteur de Lille, U1011, Lille, France.

Nature Metabolism
|November 9, 2019
PubMed
Summary

Non-alcoholic steatohepatitis (NASH) involves liver inflammation and damage. This study reveals a distinct immune gene signature in NASH, linked to specific immune cells, offering potential therapeutic targets.

More Related Videos

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.5K
Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

3.9K

Related Experiment Videos

Last Updated: Jan 4, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.3K
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.5K
Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

3.9K

Area of Science:

  • Hepatology
  • Immunology
  • Molecular Biology

Background:

  • Non-alcoholic fatty liver disease (NAFLD) progression to non-alcoholic steatohepatitis (NASH) is a growing concern.
  • NASH is characterized by liver inflammation and hepatocyte damage, distinguishing it from simple fatty liver.
  • The molecular drivers of NASH development are not fully understood.

Purpose of the Study:

  • To investigate the molecular and immune profiles associated with NASH.
  • To identify how lifestyle intervention (LSI) impacts these profiles.
  • To understand the role of immune cells in NASH pathogenesis.

Main Methods:

  • Transcriptional and immune profiling of NASH patients before and after LSI.
  • Analysis of liver microarray data and blood immune cell populations.
  • Utilized a diet-induced mouse model of NASH.

Main Results:

  • Identified a hepatic gene signature associated with NASH, which regressed with LSI, independent of weight loss.
  • NASH is linked to immune genes involved in inflammation, antigen presentation, and cytotoxic cells.
  • Observed alterations in blood immune cells (cDC1, cDC2, CD8 T cells) and increased intra-hepatic CD8 T cells in NASH patients and a mouse model.

Conclusions:

  • NASH exhibits a unique hepatic immune gene signature compared to simple steatosis or normal liver.
  • Elevated hepatic CD8 T cells and altered blood immune cells are characteristic of NASH.
  • These findings highlight the immune system's role in NASH and suggest potential therapeutic targets.